Lumexa outlines 2026 revenue of $1.045B-$1.097B while targeting 8-10 de novo openings (NASDAQ:LMRI)
Earnings Call Insights: Lumexa Imaging Holdings, Inc. (LMRI) Q1 2026 Management View "In Q1, we delivered several meaningful achievements to ...
Monday, May 18, 2026
Tag: Outlines
Electromed outlines plan to add 4-5 sales reps next year as Smart Order adoption reaches 40% of orders (NYSE:ELMD)
Earnings Call Insights: Electromed, Inc. (ELMD) Q3 fiscal 2026 Management View CEO James Cunniff framed Q3 as another milestone, saying, ...
Alx Oncology outlines interim ASPEN-09 data from ~80 patients by mid-2027 as CD47-high cohort shows 22-month median PFS (NASDAQ:ALXO)
Earnings Call Insights: ALX Oncology (ALXO) Q1 2026 Management view Seeking Alpha's Disclaimer: This article was automatically generated by an ...
Mercer outlines $60M-$80M 2026 CapEx plan as special committee reviews liquidity options (NASDAQ:MERC)
Earnings Call Insights: Mercer International (MERC) Q1 2026 Management view Richard Short (Executive VP, CFO & Secretary) said operating EBITDA ...
WEC outlines $37.5B capital plan while reaffirming 2026 EPS guidance of $5.51-$5.61 (NYSE:WEC)
Earnings Call Insights: WEC Energy Group (WEC) Q1 2026 Management view Scott Lauber said, "we reported first quarter 2026 earnings ...
SEC Outlines Crypto As Top Priority In Pro-Innovation Agenda
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure The US Securities and Exchange Commission (SEC) ...
Frp holdings outlines 2026 NOI of $37.1M-$37.7M while integrating Altman platform (NASDAQ:FRPH)
Earnings Call Insights: FRP Holdings, Inc. (FRPH) Q4 2025 Management view “2025 was a transition year operationally... As we enter ...
BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)
Earnings Call Insights: BioCardia (BCDA) Q4 2025 Management View Peter Altman, CEO, highlighted that BioCardia now has complete and final ...
Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4 (NASDAQ:GUTS)
Follow us on Google for the latest stock newsFollow Seeking Alpha on Google for the latest stock newsEarnings Call Insights: ...
Sera Prognostics outlines plan to expand partner programs to 15–17 states by year-end 2026 while maintaining cash runway through 2028 (NASDAQ:SERA)
Earnings Call Insights: Sera Prognostics (SERA) Q4 2025 Management View President and CEO Evguenia Lindgardt highlighted 2025 as a pivotal ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.